MyMD Pharmaceuticals
Pharmaceuticals - Baltimore, Maryland, United States
MyMD Pharmaceuticals Employees
MyMD Pharmaceuticals Details
MyMD is a clinical stage biotech pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control tumor necrosis factor alpha (TNF-α) and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. Supera-CBD is a drug platform based on a novel (patent pending) synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. Supera-CBD is being developed to address the rapidly growing CBD market that includes FDA approved drugs and CBD products not currently regulated as a drug.
MyMD Pharmaceuticals Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
Tag Management
Google Tag Manager
Other
Microsoft Office 365
Hosting
Flywheel